Ye Q - Search Results

1

Cancer-associated molecular signature in the tissue samples of patients with cirrhosis.

Kim JW, Ye Q, Forgues M, Chen Y, Budhu A, Sime J, Hofseth LJ, Kaul R, Wang XW. Kim JW, et al. Among authors: ye q. Hepatology. 2004 Feb;39(2):518-27. doi: 10.1002/hep.20053. Hepatology. 2004. PMID: 14768006

2

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning.

Ye QH, Qin LX, Forgues M, He P, Kim JW, Peng AC, Simon R, Li Y, Robles AI, Chen Y, Ma ZC, Wu ZQ, Ye SL, Liu YK, Tang ZY, Wang XW. Ye QH, et al. Nat Med. 2003 Apr;9(4):416-23. doi: 10.1038/nm843. Epub 2003 Mar 17. Nat Med. 2003. PMID: 12640447

3

The molecular signature of metastases of human hepatocellular carcinoma.

Budhu AS, Zipser B, Forgues M, Ye QH, Sun Z, Wang XW. Budhu AS, et al. Oncology. 2005;69 Suppl 1:23-7. doi: 10.1159/000086628. Epub 2005 Sep 19. Oncology. 2005. PMID: 16210873 Review.

4

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

Budhu A, Forgues M, Ye QH, Jia HL, He P, Zanetti KA, Kammula US, Chen Y, Qin LX, Tang ZY, Wang XW. Budhu A, et al. Cancer Cell. 2006 Aug;10(2):99-111. doi: 10.1016/j.ccr.2006.06.016. Cancer Cell. 2006. PMID: 16904609 Free article.

5

Gene expression profiling reveals potential biomarkers of human hepatocellular carcinoma.

Jia HL, Ye QH, Qin LX, Budhu A, Forgues M, Chen Y, Liu YK, Sun HC, Wang L, Lu HZ, Shen F, Tang ZY, Wang XW. Jia HL, et al. Clin Cancer Res. 2007 Feb 15;13(4):1133-9. doi: 10.1158/1078-0432.CCR-06-1025. Clin Cancer Res. 2007. PMID: 17317821

6

Positive serum hepatitis B e antigen is associated with higher risk of early recurrence and poorer survival in patients after curative resection of hepatitis B-related hepatocellular carcinoma.

Sun HC, Zhang W, Qin LX, Zhang BH, Ye QH, Wang L, Ren N, Zhuang PY, Zhu XD, Fan J, Tang ZY. Sun HC, et al. J Hepatol. 2007 Nov;47(5):684-90. doi: 10.1016/j.jhep.2007.06.019. Epub 2007 Aug 13. J Hepatol. 2007. PMID: 17854945

7

Identification of metastasis-related microRNAs in hepatocellular carcinoma.

Budhu A, Jia HL, Forgues M, Liu CG, Goldstein D, Lam A, Zanetti KA, Ye QH, Qin LX, Croce CM, Tang ZY, Wang XW. Budhu A, et al. Hepatology. 2008 Mar;47(3):897-907. doi: 10.1002/hep.22160. Hepatology. 2008. PMID: 18176954

8

EpCAM and alpha-fetoprotein expression defines novel prognostic subtypes of hepatocellular carcinoma.

Yamashita T, Forgues M, Wang W, Kim JW, Ye Q, Jia H, Budhu A, Zanetti KA, Chen Y, Qin LX, Tang ZY, Wang XW. Yamashita T, et al. Among authors: ye q. Cancer Res. 2008 Mar 1;68(5):1451-61. doi: 10.1158/0008-5472.CAN-07-6013. Cancer Res. 2008. PMID: 18316609

9

Lentiviral-mediated miRNA against osteopontin suppresses tumor growth and metastasis of human hepatocellular carcinoma.

Sun BS, Dong QZ, Ye QH, Sun HJ, Jia HL, Zhu XQ, Liu DY, Chen J, Xue Q, Zhou HJ, Ren N, Qin LX. Sun BS, et al. Among authors: ye qh. Hepatology. 2008 Dec;48(6):1834-42. doi: 10.1002/hep.22531. Hepatology. 2008. PMID: 18972404

10

EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem/progenitor cell features.

Yamashita T, Ji J, Budhu A, Forgues M, Yang W, Wang HY, Jia H, Ye Q, Qin LX, Wauthier E, Reid LM, Minato H, Honda M, Kaneko S, Tang ZY, Wang XW. Yamashita T, et al. Among authors: ye q. Gastroenterology. 2009 Mar;136(3):1012-24. doi: 10.1053/j.gastro.2008.12.004. Epub 2008 Dec 6. Gastroenterology. 2009. PMID: 19150350 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,338 results

Search Page

Filters